Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

REGN

Regeneron Pharmaceuticals (REGN)

Regeneron Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:REGN
DateTimeSourceHeadlineSymbolCompany
06/01/202208:21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
06/01/202208:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
02/01/202222:35TipRanksLeerink Partners Remains a Buy on Regeneron (REGN)NASDAQ:REGNRegeneron Pharmaceuticals Inc
23/12/202108:15PR Newswire (US)Regeneron Announces Presentation at the 40th Annual J.P. Morgan Healthcare ConferenceNASDAQ:REGNRegeneron Pharmaceuticals Inc
23/12/202104:45TipRanksRegeneron (REGN) Receives a Buy from H.C. WainwrightNASDAQ:REGNRegeneron Pharmaceuticals Inc
18/12/202101:13TipRanksRegeneron Slips Due to Potential Eye Drug CompetitorsNASDAQ:REGNRegeneron Pharmaceuticals Inc
17/12/202104:35TipRanksAnalysts Offer Insights on Healthcare Companies: Regeneron (REGN) and uniQure (QURE)NASDAQ:REGNRegeneron Pharmaceuticals Inc
15/12/202108:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
15/12/202108:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
15/12/202108:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
15/12/202108:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
15/12/202108:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
15/12/202108:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
14/12/202119:03TipRanksLeerink Partners Believes Regeneron (REGN) Won’t Stop HereNASDAQ:REGNRegeneron Pharmaceuticals Inc
13/12/202116:59PR Newswire (US)Positive Phase 3 Dupixent® (dupilumab) Data in Children 6 Months to 5 Years with Moderate-to-severe Atopic Dermatitis Featured in RAD 2021 Late-breaking SessionNASDAQ:REGNRegeneron Pharmaceuticals Inc
12/12/202104:00PR Newswire (US)New REGN5458 (BCMAxCD3) Phase 1 Data Show 75% Response Rate at Highest Dose Levels Studied in Patients with Heavily Pretreated Multiple MyelomaNASDAQ:REGNRegeneron Pharmaceuticals Inc
11/12/202110:42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
11/12/202109:42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
11/12/202109:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
11/12/202109:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
11/12/202109:36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
11/12/202109:35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
11/12/202109:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
11/12/202109:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
11/12/202109:29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
11/12/202102:19Dow Jones NewsPfizer Gets Europe OK of Cibinqo in Adults With Atopic DermatitisNASDAQ:REGNRegeneron Pharmaceuticals Inc
09/12/202109:29PR Newswire (US)New England Journal of Medicine Publishes Positive Phase 3 Dupixent® (dupilumab) Results in Children with Moderate-to-severe AsthmaNASDAQ:REGNRegeneron Pharmaceuticals Inc
09/12/202104:35TipRanksRegeneron (REGN) Gets a Buy Rating from H.C. WainwrightNASDAQ:REGNRegeneron Pharmaceuticals Inc
07/12/202108:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
04/12/202102:00PR Newswire (US)Regeneron to Participate in H.C. Wainwright & Co. Virtual EventNASDAQ:REGNRegeneron Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:REGN

Your Recent History

Delayed Upgrade Clock